Clinical Services

Development of blood vessel repair therapy accelerated

19 July, 2021

UniQuest has partnered with CSL to accelerate the development of a potential treatment for the repair of blood vessels damaged by inflammation.


Hospital pharmacy performing under pressure as mass vaccination gains momentum

13 July, 2021 by Kristin Michaels, SHPA CEO

Hospital pharmacists and technicians find themselves at the very centre of the largest public health initiative in Australia's history.


Medicinal cannabis facility planned for Toowoomba

12 July, 2021

Medibis has announced long-term plans to build a multi-million-dollar medicinal cannabis facility in Toowoomba, Queensland.


'Spider web' mechanism traps and kills viruses

12 July, 2021

Immunologists at Canada's McMaster University have discovered a mechanism that acts like a spider web — trapping and killing pathogens such as influenza or SARS-CoV-2.


PBS listing for ulcerative colitis treatment

05 July, 2021

Australians living with moderate-to-severe ulcerative colitis can now access a PBS-listed oral treatment alternative.


CleanSpace Technology CleanSpace Respirators

01 July, 2021 | Supplied by: CleanSpace Technology Pty Ltd

CleanSpace Technology's CleanSpace Respirators are designed to protect healthcare workers from airborne contaminants.


New treatment for asbestos-related cancer

01 July, 2021

Australians living with inoperable malignant mesothelioma will soon have access to an immunotherapy listed on the Pharmaceutical Benefits Scheme.


Whiteley Surfex dry-surface biofilm remover and disinfectant

01 July, 2021 | Supplied by: Whiteley

Surfex from Whiteley Medical is a dry-surface biofilm remover and disinfectant, intended for use on environmental surfaces and for non-critical medical devices such as hospital beds and theatre trolleys.


Global collaboration strives to advance heart health

30 June, 2021

The Global Cardiovascular Research Funders Forum aims to to advance the prevention, diagnosis and treatment of cardiovascular conditions such as heart attack and stroke.


What's Australia's first local Pfizer-style COVID vaccine? And when might it be in our arms? An mRNA expert explains

25 June, 2021 by Archa Fox Associate Professor and ARC Future Fellow, The University of Western Australia

A research team at Monash University hopes to develop a new mRNA vaccine, which works by the same principles as the Pfizer vaccine and could be manufactured locally.


Flinders University joins male health research alliance

23 June, 2021

Flinders University has become a research partner of the Freemasons Centre for Male Health & Wellbeing, broadening the scope and footprint of the centre's activities.


Fish oil's role in stopping superbugs

22 June, 2021

Australian scientists have discovered that regular fish oil has the potential to break down superbugs' ability to become resistant to antibiotics.


PanKind initiative sets sights on early detection of pancreatic cancer

21 June, 2021

PanKind has launched the PanKind Early Detection Initiative in a move to strategically work with the research community to improve early diagnosis of pancreatic cancer.


Promising results from Novavax Phase 3 vaccine trial

18 June, 2021

Novavax's COVID-19 vaccine demonstrated 100% protection against moderate and severe disease, with 90.4% efficacy overall, in the PREVENT-19 Phase 3 trial.


How to avoid dangerous mistakes when responding to anaphylaxis

18 June, 2021

World Allergy Week is seeking to raise awareness of allergies and anaphylaxis, with leading allergy organisations promoting important resources that could save lives.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd